Idexx Laboratories (IDXX) Receivables (2009 - 2026)

Idexx Laboratories' Receivables history runs 18 years deep, the most recent figure standing at $922.2 million for Q1 2026.

• In Q1 2026, Receivables rose 18.2% year-over-year to $922.2 million; the TTM figure through Mar 2026 stood at $922.2 million (up 18.2% YoY), while the FY2025 annual figure was $865.1 million, up 20.17% from the prior year.
• Receivables was $922.2 million for Q1 2026 at Idexx Laboratories, up from $865.1 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $922.2 million in Q1 2026 to a low of $571.8 million in Q3 2022.
• Historically, Receivables has averaged $719.7 million across 5 years, with a median of $719.9 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Receivables advanced 5.78% in 2024, then climbed 20.17% in 2025.
• A 5-year view of Receivables shows it stood at $591.4 million in 2022, then rose by 15.07% to $680.5 million in 2023, then climbed by 5.78% to $719.9 million in 2024, then rose by 20.17% to $865.1 million in 2025, then gained by 6.61% to $922.2 million in 2026.
• The last three Receivables figures came in at $922.2 million (Q1 2026), $865.1 million (Q4 2025), and $855.6 million (Q3 2025), per Business Quant data.